Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Artiva Biotherapeutics
Biotech
Former FDA leader takes new biotech Turn—Chutes & Ladders
Former FDA leader takes new biotech Turn. Amgen lures back exec as new finance chief. Antag tags obesity leader as new CEO.
Darren Incorvaia
,
Zoey Becker
May 22, 2026 8:30am
J&J innovator vaults to Valo—Chutes & Ladders
Apr 11, 2025 8:30am
Artiva upsizes IPO to $167 million
Jul 19, 2024 4:56am
Artiva sets out $135M IPO to push NK cell therapy through trials
Jul 15, 2024 8:33am
Artiva plans IPO to fund NK cell therapy's autoimmune trials
Jul 1, 2024 7:48am
AACR: New Affimed data disappoints after Nasdaq flags stock dip
Apr 17, 2023 12:52pm
